Figure 2 | Scientific Reports

Figure 2

From: Active ingredients Isorhamnetin of Croci Srigma inhibit stomach adenocarcinomas progression by MAPK/mTOR signaling pathway

Figure 2The alternative text for this image may have been generated using AI.

Function and target analysis of active ingredients of Croci Stigma. (A) Active ingredients and targets of Croci Stigma analyzed by Go enrichment analysis. (B) The transcription factors regulating active ingredient targets. (C) The transcription factor regulating active ingredient targets.

Back to article page